Soleno Therapeutics Inc (SLNO): Next-Year EPS Estimate 72.91%
As of 2026-05-28, Soleno Therapeutics Inc (SLNO) has a next-year EPS growth estimate of 72.91%. Featured in 2 EPS revision reports, most recently on 2026-04-13.
On 2026-05-24, analyst consensus for SLNO's next-year EPS growth shifted from 60.02% to 72.91% — a positive change of 12.89 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 999.36%.
What's Driving This
The primary structural driver is the analysts' upward revision to next-year EPS growth, raised from 60.02% to 72.91% on 2026-05-24. No specific headlines are available to explain this upgrade, so the catalyst remains unclear. Since the initial revision, the net EPS estimate has risen by 13.73 percentage points across two additional upward moves, indicating momentum has continued beyond the first change.
Generated 2026-08-25 from news as of 2026-05-28
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 72.91%
- EPS growth this year
- 999.36%
- EPS next quarter (est)
- $0.99
- Last price
- $53.01
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-28 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-27 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-26 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-25 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-24 | 72.91% | 999.36% | $0.99 | $53.01 |
| 2026-05-21 | 60.02% | 968.80% | $0.96 | $53.01 |
| 2026-05-20 | 61.21% | 877.21% | $0.92 | $53.01 |
| 2026-05-19 | 61.21% | 877.21% | $0.92 | $53.01 |
| 2026-05-18 | 59.18% | 912.39% | $0.94 | $53.01 |
| 2026-05-17 | 59.18% | 912.39% | $0.94 | $53.01 |
| 2026-05-14 | 59.18% | 912.39% | $0.94 | $52.99 |
| 2026-05-13 | 59.18% | 912.39% | $0.94 | $52.97 |
| 2026-05-12 | 59.18% | 912.39% | $0.94 | $52.93 |
| 2026-05-11 | 59.18% | 912.39% | $0.68 | $52.94 |
| 2026-05-10 | 59.18% | 912.39% | $0.68 | $52.95 |
| 2026-05-07 | 59.18% | 912.39% | $0.68 | $52.95 |
| 2026-05-06 | 59.18% | 912.39% | $0.68 | $52.94 |
| 2026-05-05 | 59.18% | 912.39% | $0.68 | $52.92 |
| 2026-05-04 | 59.18% | 912.39% | $0.68 | $52.90 |
| 2026-05-03 | 59.18% | 912.39% | $0.68 | $52.87 |
| 2026-04-30 | 59.18% | 912.39% | $0.68 | $52.82 |
| 2026-04-29 | 59.18% | 912.39% | $0.68 | $52.78 |
| 2026-04-28 | 59.18% | 912.39% | $0.68 | $52.76 |
| 2026-04-27 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-26 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-24 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-23 | 59.18% | 912.39% | $0.68 | $52.83 |
| 2026-04-22 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-21 | 59.18% | 912.39% | $0.68 | $52.69 |
| 2026-04-20 | 59.18% | 912.39% | $0.68 | $52.67 |
Reports Featuring SLNO
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Soleno Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-28, Soleno Therapeutics Inc (SLNO) has a next-year EPS growth estimate of 72.91%, based on analyst consensus.
When was the latest EPS estimate revision for SLNO?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 60.02% to 72.91%.
What sector and industry does Soleno Therapeutics Inc belong to?▾
Soleno Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SLNO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Soleno Therapeutics Inc (SLNO) appears here because it was detected by our daily top-EPS-revision-performer screen.